Difference between revisions of "Foregut primary carcinomas"

Jump to navigation Jump to search
(→‎Foregut: +IHC)
Line 12: Line 12:
*[[Pancreas]].<ref name=pmid23630303>{{cite journal |authors=Jennings RE, Berry AA, Kirkwood-Wilson R, Roberts NA, Hearn T, Salisbury RJ, Blaylock J, Piper Hanley K, Hanley NA |title=Development of the human pancreas from foregut to endocrine commitment |journal=Diabetes |volume=62 |issue=10 |pages=3514–22 |date=October 2013 |pmid=23630303 |pmc=3781486 |doi=10.2337/db12-1479 |url=}}</ref>
*[[Pancreas]].<ref name=pmid23630303>{{cite journal |authors=Jennings RE, Berry AA, Kirkwood-Wilson R, Roberts NA, Hearn T, Salisbury RJ, Blaylock J, Piper Hanley K, Hanley NA |title=Development of the human pancreas from foregut to endocrine commitment |journal=Diabetes |volume=62 |issue=10 |pages=3514–22 |date=October 2013 |pmid=23630303 |pmc=3781486 |doi=10.2337/db12-1479 |url=}}</ref>
*Lower respiratory tract.
*Lower respiratory tract.
==IHC==
Foregut carcinomas are typically:
*CK7 +ve.
*CK20 -ve.
*CDX2 -ve.
A foregut primary panel for liver lesions:
*AE1/AE3, CK7, CK20, CK19, CDX2, CA-125, HepPar-1, GATA3, TTF-1.


==See also==
==See also==
48,830

edits

Navigation menu